77 related articles for article (PubMed ID: 24480919)
1. Uncertainty in measurements of ¹⁸F blood concentration and its effect on simplified dynamic PET analysis.
Sattarivand M; Borel S; Armstrong J; Kusano M; Poon I; Caldwell C
J Nucl Med Technol; 2014 Mar; 42(1):21-7. PubMed ID: 24480919
[TBL] [Abstract][Full Text] [Related]
2. Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
Hapdey S; Buvat I; Carson JM; Carrasquillo JA; Whatley M; Bacharach SL
J Nucl Med; 2011 Apr; 52(4):634-41. PubMed ID: 21421718
[TBL] [Abstract][Full Text] [Related]
3. Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Sundaram SK; Freedman NM; Carrasquillo JA; Carson JM; Whatley M; Libutti SK; Sellers D; Bacharach SL
J Nucl Med; 2004 Aug; 45(8):1328-33. PubMed ID: 15299057
[TBL] [Abstract][Full Text] [Related]
4. The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.
Goethals I; D'Asseler Y; Dobbeleir A; Deblaere K; Ham H
Nucl Med Commun; 2010 Mar; 31(3):227-31. PubMed ID: 20023593
[TBL] [Abstract][Full Text] [Related]
5. Subcentimeter tumor lesion delineation for high-resolution 18F-FDG PET images: optimizing correction for partial-volume effects.
Wallstén E; Axelsson J; Sundström T; Riklund K; Larsson A
J Nucl Med Technol; 2013 Jun; 41(2):85-91. PubMed ID: 23658206
[TBL] [Abstract][Full Text] [Related]
6. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.
Lehtiö K; Oikonen V; Grönroos T; Eskola O; Kalliokoski K; Bergman J; Solin O; Grénman R; Nuutila P; Minn H
J Nucl Med; 2001 Nov; 42(11):1643-52. PubMed ID: 11696633
[TBL] [Abstract][Full Text] [Related]
7. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
[TBL] [Abstract][Full Text] [Related]
8. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
9. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
[TBL] [Abstract][Full Text] [Related]
10. Measurement of input functions in rodents: challenges and solutions.
Laforest R; Sharp TL; Engelbach JA; Fettig NM; Herrero P; Kim J; Lewis JS; Rowland DJ; Tai YC; Welch MJ
Nucl Med Biol; 2005 Oct; 32(7):679-85. PubMed ID: 16243642
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.
Tylski P; Stute S; Grotus N; Doyeux K; Hapdey S; Gardin I; Vanderlinden B; Buvat I
J Nucl Med; 2010 Feb; 51(2):268-76. PubMed ID: 20080896
[TBL] [Abstract][Full Text] [Related]
12. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
13. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Sam S; Shon IH; Vinod SK; Lin P; Lin M
J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005
[TBL] [Abstract][Full Text] [Related]
14. Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods.
Greuter HN; Boellaard R; van Lingen A; Franssen EJ; Lammertsma AA
J Nucl Med Technol; 2003 Dec; 31(4):206-9. PubMed ID: 14657286
[TBL] [Abstract][Full Text] [Related]
15. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y
Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312
[TBL] [Abstract][Full Text] [Related]
16. Image-derived input function from the vena cava for 18F-FDG PET studies in rats and mice.
Lanz B; Poitry-Yamate C; Gruetter R
J Nucl Med; 2014 Aug; 55(8):1380-8. PubMed ID: 24914058
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sager S; Asa S; Yilmaz M; Uslu L; Vatankulu B; Halaç M; Sönmezoglu K; Kanmaz B
J Cancer Res Ther; 2014; 10(4):922-6. PubMed ID: 25579529
[TBL] [Abstract][Full Text] [Related]
18. Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
van der Weerdt AP; Boellaard R; Knaapen P; Visser CA; Lammertsma AA; Visser FC
J Nucl Med; 2004 Feb; 45(2):169-75. PubMed ID: 14960632
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
20. Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer?
Goerres GW; Schmid DT; Eyrich GK
Dentomaxillofac Radiol; 2003 Nov; 32(6):365-71. PubMed ID: 15070838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
